BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20160313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20161106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171113
DTEND;VALUE=DATE:20171115
DTSTAMP:20170614T152802Z
CREATED:20170614T152324Z
LAST-MODIFIED:20170614T152802Z
UID:16465-1510531200-1510703999@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs USA
DESCRIPTION:SMi Group will host this year’s Superbugs and Superdrugs USA on November 13-14\, 2017 in Iselin\, New Jersey. \nAntimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA\, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy\, whilst honing in on clinical developments in areas such as immunotherapy\, toxoid based vaccines and anti-body drug conjugates. \nAs methods move away from traditional small molecule antibiotics\, this is critical time for AMR experts\, government bodies and industry leaders\, to come together and share ideas on the latest developments in treatment and prevention. \nFeatured Speakers Include: \n\nAnthony Simon Lynch\, Senior Scientific Director\, Janssen\nWilliam Weiss\, Director\, Pre-Clinical Services\, UNT Health Science Center\nJohn Rex\, Chief Medical Officer & Director\, F2G; Chief Strategy Officer\, CARB-X\nChristopher Houchens\, Branch Chief\, Antibacterials Program\, BARDA\nAnnaliesa Anderson\, Vice President & CSO Bacterial Vaccines\, Pfizer\nOlga Danilchanka\, Microbiome Lead\, Merck\nChristopher McMaster\, President & CEO\, DemovaMed\nObadiah Plante\, Director of Research\, Visterrra\nTim Opperman\, Senior Research Scientist\, Microbiotix\nKen Stover\, Senior Director\, Infectious Diseases and Vaccines\, MedImmune\nMike Westby\, Director\, Centauri Therapeutics\n\nAgenda highlights: \n\nGuidelines for successfully seeking funding and partnership with updates on the CARB-X initiative\nUnderstand the importance of supporting natural immunity and the microbiome for reducing infection from resistant bacteria\nNew insight into developments for treating gram-negative infections\nExplore the emerging and non-traditional approaches to antimicrobial drug development\, including biologic drugs and combination treatments\n\nFor further information visit http://www.superbugs-usa.com/globalbiodefense or contact the team on Tel: +44 (0)20 7827 6000 / Email: events@smi-online.co.uk \nGlobal Biodefense is an official media partner of Superbugs & Superdrugs USA.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-usa-2/
LOCATION:Renaissance Woodbridge Hotel\, 515 US-1\, Iselin\, NJ\, 08830\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2017/06/superbugs-superdrugs-usa-700.jpg
END:VEVENT
END:VCALENDAR